Jupiter Neurosciences held annual shareholder meeting, with 59% of shares represented

Jupiter Neurosciences held its annual shareholder meeting on July 22, 2026.

• Shareholders ratified Cherry Bekaert as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Investors adopted an amendment to the 2025 Equity Incentive Plan to add 5.25 million shares for issuance under the plan.
• Shareholders authorized a reverse stock split, with the ratio set within a 1-for-10 to 1-for-100 range at the board’s discretion.